Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Tuberculosis vaccine H4IC - AJ Vaccines

Next Previous
X
Search
Drug Profile

Tuberculosis vaccine H4IC - AJ Vaccines

Alternative Names: Adjuvanted TB subunit vaccine H4IC - AJ Vaccines/sanofi pasteur; AERAS-404; Ag85B-TB10.4-IC31; H4+IC31; H4/AERAS-404+IC31®; H4/IC31 vaccine; H4:IC31; HyVac4; HyVac4-IC31; Tuberculosis vaccine H4IC - AJ Vaccines/sanofi

Latest Information Update: 22 Feb 2023

Price : $50 *
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator Statens Serum Institut
  • Developer Aeras; AJ Vaccines; National Institute of Allergy and Infectious Diseases; Sanofi
  • Class Adjuvants; Antituberculars; Recombinant fusion proteins; Subunit vaccines; Synthetic vaccines; Tuberculosis vaccines
  • Mechanism of Action Immunostimulants
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No

Highest Development Phases

  • Phase II Tuberculosis

Most Recent Events

  • 22 Feb 2023 Discontinued - Preclinical for Tuberculosis in Austria (IM)
  • 22 Feb 2023 Discontinued - Preclinical for Tuberculosis in Denmark (IM)
  • 28 Oct 2019 No recent reports of development identified for phase-I development in Tuberculosis in Netherlands (IM, Injection)

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:
  • Contacting your organization’s admin about adding this content to your AdisInsight subscription
  • Buying a PDF version of any individual profile
  • Request a free trial
If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top